Pakistan recalls injectable medicine amid eye infection reports, initiates probe

ISLAMABAD: Pakistan’s interim health minister Nadeem Jan said on Sunday the government had recalled an injectable medicine from the market after receiving reports it had caused eye infections and loss of sight among patients in the Kasur, Multan, Lahore, and Sadiqabad districts located in the eastern Punjab province.
According to media reports, the caretaker administration in Punjab formed a five-member committee to investigate the issue, following complaints related to a locally manufactured injection called Avastin which was used by diabetic patients in the province.
The federal health minister invited his provincial counterpart to Islamabad to discuss the issue in the wake of this development. He said authorities had launched an investigation and would soon assign responsibility for the matter.
“Investigations are ongoing,” Jan said in a televised statement. “A committee has been formed, comprising five of our most senior experts, who will analyze the issue from all angles and provide us with a comprehensive report within the next three days.”
“As of now, the batch of medicine in question has been recalled,” he continued. “It is now in our possession, and its sales are prohibited.”
The minister explained the investigation team was tasked with determining whether the problem was caused by the medicine itself, issues in its supply chain, the skill level of the administering doctors, or the sterilization process.
He added the government had filed a police report against two individuals representing the supply company and had initiated legal action against them.
Jan assured the public of a transparent inquiry, adding the authorities would share their findings and prosecute those responsible for causing harm to patients.

Pakistan recalls injectable medicine amid eye infection reports, initiates probe